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Letter to the Editor
Most published and unpublished dissertations should be
excluded from meta-analyses: comment on Moyer et al.
Moyer et al. [1] systematically collected published
and unpublished dissertations evaluating psycho-
social interventions for cancer patients and exam-
ined the methodological quality of these studies.
They concluded that because published and
unpublished dissertations diﬀer little in methodo-
logical adequacy, the inclusion of unpublished
dissertations in meta-analyses is desirable in order
to avoid publication bias.
Instead of focusing explicitly on quality, how-
ever, the Moyer et al.’s [1] analysis combined
criteria intended to reﬂect adequate reporting of
results from trials with criteria that indeed reﬂect
quality, or the likelihood that trial results reﬂect
underlying clinical realities. For instance, their ﬁrst
four criteria concern whether the dissertation
reported the number of participants approached
for consent to participate in a study; reported the
number initially participating; reported compari-
sons of participants to patients approached, but
not participating; and reported the number drop-
ping out of treatment. A dissertation could have
earned a perfect score on these ratings for reporting
this information, despite reporting extremely low
uptake and low retention of participants, which
would suggest a high probability of bias and
potentially poor external and internal validity.
Nonetheless, the evidence reported by Moyer
et al. [1] makes it clear that both published and
unpublished dissertations are generally of poor
quality. Dissertations with at least 10 patients per
cell were included in their analyses, with mean
numbers of initial participants per cell of 37.7
(SD5 42.5) in published dissertations and 29.4
(SD5 23.94) in unpublished dissertations. Moyer
et al. do not indicate how many small, grossly
underpowered studies were included in either the
published or unpublished dissertations. However,
the mean cell sizes and large standard deviations
for mean participants per cell suggest a substantial
number.
The problems posed by studies with small cell
size are not widely appreciated [2]. As demon-
strated by Kraemer et al. [3], the inclusion of small,
underpowered trials in meta-analyses results in
substantially overestimated eﬀect estimates due
to conﬁrmatory publication bias. Statistical
correction is impossible with a proportionately
large number of underpowered studies. To achieve
80% statistical power to detect a moderate eﬀect
size (e.g., d5 0.50), 64 patients would need to be
randomized to each of the intervention and control
groups. A small study of 20 patients per group
would have only 34% power to detect a moderate
eﬀect size. With 20 patients per group, a fairly large
eﬀect size of 0.65 would be needed just for
statistical signiﬁcance. The problem is even worse
than that; however, as small studies with true null
eﬀects that cross the po0.05 threshold do it by
varying degrees. With 20 patients per group and a
true null eﬀect, the expected standardized eﬀect size
in a meta-analysis of statistically signiﬁcant trials
would be 0.90–1.00. Thus, albeit counter-intuitive,
grossly underpowered studies with positive results,
including most published and unpublished disser-
tations, are most often false positives.
Cuijpers et al. [4] recently showed that, when only
high-quality studies were considered, the eﬀect
estimates for psychotherapy for depression de-
creased from large (d5 0.74) to small (d5 0.22).
Quality criteria included sample size, use of
intention-to-treat analyses, independent randomiza-
tion, utilization of treatment manuals, and treat-
ment integrity. Of the studies reviewed by Moyer
et al., 17% of published dissertations and 38% of
non-published dissertations were not randomized
trials at all; only 12 and 6% of published and
unpublished dissertations, respectively, used intent-
to-treat analyses; only 11 and 18% described a
speciﬁc method of randomization and measures to
prevent subterfuge; fewer than half in either group
used treatment manuals; and only 67 and 49%
monitored intervention implementation. Most
studies reported that they assessed baseline equiva-
lence, but Moyer et al. do not report whether or not
this was achieved. Indeed, ﬁndings of baseline
equivalence of intervention and control groups,
based on the lack of statistically signiﬁcant diﬀer-
ences, are often meaningless with small studies
because there is too little power to detect diﬀerences
that may be individually or collectively decisive in
determining the outcome of a trial.
The literature concerning psychosocial interven-
tions for cancer patients has been shown to have
serious shortcomings in terms of methodology [5]
and clinical and statistical heterogeneity [6]. The
pervasiveness of these problems raises concerns
about whether studies should automatically be
included in meta-analyses based simply on their
availability [2] or even whether a summary estimate
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of eﬀect size derived from the overall literature is
meaningful [7]. Statistical adjustment or other
methods to assess the inﬂuence of poor-quality
studies on the results of meta-analyses do not work
when many or most studies share similar metho-
dological problems and are of generally low
quality. Solutions to the problem of adequately
gauging the eﬃcacy of psychosocial studies will not
be found by introducing even more small, metho-
dologically ﬂawed studies into consideration. In-
stead, we need to rely on methodologically stronger
studies with adequate sample sizes.
The uncritical inclusion of unpublished disserta-
tion studies in meta-analyses should be discour-
aged. A more judicious decision would be to base
inclusion in meta-analyses on study quality or, at a
minimum, to present results for high- and low-
quality studies separately [8]. Based on the results
presented by Moyer et al., most dissertations,
regardless of their publication status, would be
graded as low quality based on any of the
commonly used quality assessment tools.
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